MJ Willemse

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia

OJHM Verhagen, MJ Willemse, W. B. Breunis et al. · Leukemia · 2000 · 201 citations

Germline Igh Probes, Mixed-phenotype Acute Leukemia, Diagnosis +16

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL

MJ Willemse · Blood · 2002 · 165 citations · Full text

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

VHJ van der Velden, DCH Jacobs, AJM Wijkhuijs et al. · Leukemia · 2002 · 142 citations

Hematological Malignancy, Bone Marrow Failure, Mixed-phenotype Acute Leukemia +10

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR

VHJ van der Velden, MJ Willemse, CE van der Schoot et al. · Leukemia · 2002 · 123 citations

Hematological Malignancy, Lymphoid Neoplasia, Element Rearrangements +11

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group

Andrea Biondi, MG Valsecchi, Taku Seriu et al. · Leukemia · 2000 · 116 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Oncology +12